Nov 06, 2025
1:400
For every 400 shares held, investors received 1.
The split itself did not change the total investment value.
Mindbio Therapeutics Corp. (GETTEX:WF60) operates in the Pharmaceuticals: major industry.
Mindbio Therapeutics Corp. company overviewMindbio Therapeutics Corp.'s most recent stock split was on November 6, 2025. It was a 1-for-400 reverse split, so shareholders received 1 share for every 400 they held.
Mindbio Therapeutics Corp. has split its stock once. This history records one reverse split, on November 6, 2025.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Mindbio Therapeutics Corp.'s 1-for-400 reverse split on November 6, 2025, every 400 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Mindbio Therapeutics Corp. has not announced a new split in our records. Its most recent split was on November 6, 2025, less than a year ago. Companies announce splits in advance, and any new GETTEX:WF60 split will appear on this page.
Already premium?